Aptus Fortified Value
ALTAR
Score™
11.3% info Recommen-
dation
SPECULATIVE
2019E    2020E
P/E
ratio
13.1x P/Sales
ratio
1.9x
P/BV
ratio
3.6x Div.
yield
2.0%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
FTVA tracks an index of 50 undervalued US companies selected by three fundamental measures and equally weighted. The fund excludes the financial sector.

FUND BASICS
Category US Equities
Fund Sponsor Aptus Capital Advisors
Website ftva.aptusetfs.com
Inception date Oct 31, 2017
Assets (mns) $63
Currency USD
Expense ratio 79 bp
Distributions Annually

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian
Weighting Equal
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 50
Wgt avg mkt cap (mns) $45,310
Large cap (>$10bn) 64.5%
Mid cap ($2-10bn) 35.5%
Small cap (<$2bn) 0.0%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
BIOGEN IDEC INC 2.4 %
MICHAEL KORS HOLDINGS LTD 2.3 %
ABBVIE INC 2.2 %
NETAPP INC 2.2 %
JAZZ PHARMACEUTICALS PLC 2.2 %
LAM RESEARCH CORP 2.2 %
APPLIED MATERIALS INC 2.2 %
UNITEDHEALTH GROUP INC 2.1 %
BRISTOL-MYERS SQUIBB CO 2.1 %
ILLINOIS TOOL WORKS 2.1 %
Total 22.1 %

TOP COUNTRY EXPOSURE
UNITED STATES 91.3 %
BRITAIN 4.4 %
IRELAND 4.2 %








HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru October 31)
Year-to-date 1 year 5 years 10 years Since Incep.
12.7% 1.8% -- -- 1.0%

Market Correlations
versus... Beta R-squared
S&P500 1.16 89%
MSCI EAFE 1.14 67%
MSCI Emg. Mkts. 0.84 56%

Technical Indicators
Recent close $27.58
30d moving avg. $26.63
Annualized volatility 18.1%
Short interest (ETF) 0.0%
Relative strength (RSI) 70

Liquidity measures
Avg. volume (thou.) 9
Turnover 0.4%
Bid/Ask (% of price) 0.14%
ADV underlying (mns) $11,851

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the Aptus Fortified Value ETF based on the alternatives' overlap in portfolio holdings with FTVA. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: FTVA Expense: 79 bp ALTAR Score™: 11.3%


ALTERNATIVE ETFs BASED ON OVERLAP WITH FTVA
Ticker Fund
Name
Overlap1
vs FTVA
(%)
Expense
ratio
(bp)
Savings
vs FTVA
(bp)
ALTAR
Score™
(%)
ALTAR
vs FTVA
(%)
COWZ Pacer US Cash Cows 100 26.7 49 30 9.8 -1.5
MOAT Mkt Vectors Morningstar Wide Moat Focus 20.3 49 30 6.3 -5.0
SDOG ALPS Sector Dividend Dogs 20.3 40 39 9.3 -2.1
PJP Invesco Dynamic Pharmaceuticals 18.9 56 23 9.8 -1.5
QSY WisdomTree U.S. Quality Shareholder Yield 18.8 38 41 6.9 -4.4
SPDV AAM S&P 500 High Dividend Value 17.9 29 50 10.7 -0.7
FLQL Franklin LibertyQ U.S. Equity 17.2 15 64 6.8 -4.5
QQXT First Trust NASDAQ-100 Ex-Tech 17.1 60 19 6.0 -5.3
IYH iShares US Healthcare 16.4 43 36 6.4 -4.9
JHMH John Hancock Multifactor Health Care 16.3 40 39 6.8 -4.5
QDIV Global X S&P 500 Quality Dividend 16.2 20 59 7.0 -4.3
XLV Health Care Select Sector SPDR 16.2 13 66 7.3 -4.0
FHLC Fidelity MSCI Health Care 16.1 8 71 6.0 -5.4
VHT Vanguard Health Care 16.1 10 69 5.9 -5.4
VALQ American Century STOXX U.S. Quality Value 16.1 29 50 7.7 -3.7
DTN WisdomTree Dividend Ex-Financials 16.0 38 41 7.8 -3.5
IEIH iShares Evolved U.S. Innovative Healthcare 15.9 18 61 4.8 -6.5
RNDV US Equity Dividend Select 15.8 50 29 7.7 -3.6
DSTL Distillate US Fundamental Stability & Value 15.7 39 40 7.2 -4.1
RYH Invesco S&P Equal Weight Healthcare 15.4 40 39 7.2 -4.2

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
Aptus Fortified Value
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

SPECULATIVE

Deeply undervalued but risky. A rating of SPECULATIVE is assigned to ETFs with ALTAR Scores in the top quintile (the top 20%) of their category, indicating exceptional appreciation potential. However, often these are narrowly-focused funds or in industries with structural issues, which may also make them very risky. Nonetheless they may still be useful as part of a well-diversified portfolio.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 36.6 %
Divided by: Fwd. P/BV 3.0 x
Less: Expense ratio 79 bp
Equals: ALTAR Score 11.3 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.69 CATEGORY
AVERAGE
1.55
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.